Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence
Dermatologic Therapy · 2022-12 · 35 (12)
DOI: 10.1111/dth.15903 ↗At a glance
Übersichtsarbeit in Dermatologic Therapy, published online on 2022-10-21. Written by Bruna Bravo and 4 co-authors. Institution: Bravo's Clinic, Rio de Janeiro, Brazil. Major MEDLINE topics: Skin Aging, Dermal Fillers, Cosmeceuticals, Botulinum Toxins, Type A. Cited 173 times so far (Crossref); 45 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Cosmetic Active International, L'Oréal.
Abstract (original language)
Skin aging goes beyond a chronological process and also results from extrinsic factors referred to as the exposome. Hyaluronic acid (HA) is an important component of the extracellular matrix, with loss starting at 25 years old. While many studies of HA concern topical use, few literature reviews only address the use of topical HA in dermatology. This review describes the different characteristics of HA‐containing cosmeceuticals, with a focus on skin aging and the impact of exposome factors on HA synthesis and degradation. A review was performed using the terms HA, hyaluronan, topical, dermatology, cosmetic, aging treatment, exposome, and cosmeceuticals. Results are also presented from a recent randomized controlled trial (RCT), which investigated the additional benefit of using a HA epidermic filler (HA‐filler serum) combined with Botulinum toxin type A (BoNTA) to treat signs of skin aging. Subjects were randomized to two groups: HA‐filler serum starting 24 h after the BoNTA injection then twice daily for 24 weeks, or the control group, which received BoNTA. HA is a key ingredient used in cosmeceuticals for its hydration/antiaging properties (hygroscopic, rheological, and viscoelastic). Several clinical studies indicate that HA is both well tolerated and effective, adjuvant to both post‐surgical and facial rejuvenation procedures. In the RCT, one of few studies to combine BoNTA and HA with a 6‐month follow‐up, the HA‐filler serum lengthened the duration of BoNTA's effect in reducing wrinkles. Numerous studies support HA‐based cosmeceuticals as a noninvasive, effective solution for improving skin hydration and rejuvenation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Bravo's Clinic, Rio de Janeiro, Brazil.
- Scientific Expertise, Cosmetic Active, L'Oréal Brasil, Rio de Janeiro, Brazil.
- Cosmetic Active International, L'Oréal, Paris, France.
ORCID profiles: Bruna Bravo, Priscila Correia, José Euzébio Gonçalves Junior, Beatriz Sant'Anna, Delphine Kerob
Funding
- Cosmetic Active International, L'Oréal
Cite
APA
Bravo, B., Correia, P., Gonçalves Junior, J. E., Sant'Anna, B., & Kerob, D. (2022). Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence. Dermatologic Therapy, 35(12). https://doi.org/10.1111/dth.15903
Vancouver
Bravo B, Correia P, Gonçalves Junior JE, Sant'Anna B, Kerob D. Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence. Dermatologic Therapy. 2022;35(12). doi:10.1111/dth.15903
BibTeX
@article{Bravo2022,
author = {Bravo, Bruna and Correia, Priscila and Gonçalves Junior, José Euzébio and Sant'Anna, Beatriz and Kerob, Delphine},
title = {Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence},
journal = {Dermatologic Therapy},
year = {2022},
volume = {35},
number = {12},
doi = {10.1111/dth.15903}
}
EUVIMED